CheckMyRecalls

Eugia US LLC recalls Lidocaine HCl Injection

Published
10 Jun 2026
Units affected
168,300 vials
Agency
FDA
Country
United States

The hazard

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Brand / company
Eugia US LLC
Codes / lots
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 10 Jun 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.